Wed, September 21, 2022
Tue, September 20, 2022
Mon, September 19, 2022
Fri, September 16, 2022
Thu, September 15, 2022
Wed, September 14, 2022
Tue, September 13, 2022
Mon, September 12, 2022
Fri, September 9, 2022
Thu, September 8, 2022

Zhiqiang Shu Initiated (BPMC) at Strong Buy and Held Target at $90 on, Sep 14th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-90-on-sep-14th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Zhiqiang Shu of Berenberg, Initiated "Blueprint Medicines Corporation" (BPMC) at Strong Buy and Held Target at $90 on, Sep 14th, 2022.

Zhiqiang has made no other calls on BPMC in the last 4 months.



There are 11 other peers that have a rating on BPMC. Out of the 11 peers that are also analyzing BPMC, 3 agree with Zhiqiang's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $80 on, Friday, September 9th, 2022
  • Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $57 on, Thursday, August 18th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Decreased Target to $65 on, Thursday, May 19th, 2022


These are the ratings of the 8 analyists that currently disagree with Zhiqiang


  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Increased Target to $90 on, Tuesday, September 6th, 2022
  • Eun Yang of "Jefferies" Maintained at Strong Buy with Increased Target to $84 on, Monday, August 22nd, 2022
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $100 on, Thursday, August 18th, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $80 on, Wednesday, August 17th, 2022
  • Derek Archila of "Wells Fargo" Maintained at Sell with Increased Target to $41 on, Wednesday, August 17th, 2022
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Decreased Target to $115 on, Wednesday, August 3rd, 2022
  • Terence Flynn of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $143 on, Wednesday, August 3rd, 2022
  • David Lebowitz of "Citigroup" Downgraded from Hold to Strong Sell and Decreased Target to $41 on, Friday, June 10th, 2022

Publication Contributing Sources